{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T03:04:33Z","timestamp":1793070273229,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Grant-in-Aid for Scientific Research"},{"name":"Grant-in-Aid for Scientific Research"},{"name":"Grant-in-Aid for Scientific Research"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Kr\u00fcppel-like factor 5 (KLF5) is an intrinsically disordered transcription factor involved in cardiac remodeling, cancer, and metabolic diseases. Targeting KLF5 has been a persistent challenge in drug development due to its structural inaccessibility. We investigated cardioprotective effects of NC114, a rationally designed small molecule that mimics a short, hydrophobic \u03b1-helical motif in KLF5, thereby disrupting its protein\u2013protein interactions. Adult C57BL\/6J male mice underwent transverse aortic constriction (TAC) or sham surgery, followed by administration of NC114 or vehicle. NC114-treated TAC mice exhibited preserved cardiac function, reduced heart weight-to-body weight ratio, and markedly attenuated interstitial fibrosis. Gene expression analysis demonstrated decreased cardiac expression of\n                    <jats:italic>Klf5<\/jats:italic>\n                    ,\n                    <jats:italic>Nppb<\/jats:italic>\n                    ,\n                    <jats:italic>Tgfb1<\/jats:italic>\n                    ,\n                    <jats:italic>PAI-1<\/jats:italic>\n                    ,\n                    <jats:italic>Col1a1<\/jats:italic>\n                    , and\n                    <jats:italic>Fn1<\/jats:italic>\n                    . NC114 also suppressed oxidative stress and reduced phosphorylation of PKC\u03b4 and expression of HIF-1\u03b1 during the early phase post-TAC. Metabolomic profiling revealed that NC114 treatment reversed TAC-induced accumulation of organic and amino acids. NC114, a novel peptidomimetic molecule, targets the undruggable transcription factor KLF5 to attenuate cardiac hypertrophy, fibrosis, and metabolic dysregulation in pressure overload-induced heart failure. This study highlights the potential of KLF5 inhibition as a therapeutic strategy in cardiovascular disease.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-32155-y","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T17:36:47Z","timestamp":1768239407000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Targeting the undruggable transcription factor, KLF5, with a peptidomimetic small molecule, NC114, attenuates pressure overload-induced cardiac remodeling and fibrosis"],"prefix":"10.1038","volume":"16","author":[{"given":"Thanachai","family":"Methatham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuka","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Tomida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamaki","family":"Ishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Uosaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Sakashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryozo","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Aizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"32155_CR1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cardfail.2021.01.022","volume":"27","author":"B Bozkurt","year":"2021","unstructured":"Bozkurt, B. et al. Universal definition and classification of heart failure: a report of the heart failure society of America, heart failure association of the European society of cardiology, Japanese heart failure society and writing committee of the universal definition of heart failure. J. Cardiac Fail. 27, 387\u2013413 (2021).","journal-title":"J. Cardiac Fail."},{"key":"32155_CR2","unstructured":"Martin, S. S. et al. 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association. Circulation (2025)."},{"key":"32155_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/ehf2.12005","volume":"1","author":"P Ponikowski","year":"2014","unstructured":"Ponikowski, P. et al. Heart failure: preventing disease and death worldwide. ESC Heart Fail. 1, 4\u201325 (2014).","journal-title":"ESC Heart Fail."},{"key":"32155_CR4","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.jacc.2024.06.002","volume":"84","author":"W Committee","year":"2024","unstructured":"Committee, W. et al. 2024 ACC Expert Consensus decision pathway on Clinical Assessment, Management, and trajectory of patients hospitalized with heart failure focused update: a report of the American College of Cardiology Solution Set Oversight Committee. J. Am. Coll. Cardiol. 84, 1241\u20131267 (2024).","journal-title":"J. Am. Coll. Cardiol."},{"key":"32155_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s10741-024-10454-2","volume":"30","author":"AJ Chang","year":"2025","unstructured":"Chang, A. J. et al. Changing the paradigm in heart failure: shifting from treatment to prevention. Heart Fail. Rev. 30, 177\u2013189 (2025).","journal-title":"Heart Fail. Rev."},{"key":"32155_CR6","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1007\/s11897-014-0220-x","volume":"11","author":"SM Dunlay","year":"2014","unstructured":"Dunlay, S. M. & Roger, V. L. Understanding the epidemic of heart failure: past, present, and future. Curr. Heart Fail. Rep. 11, 404\u2013415 (2014).","journal-title":"Curr. Heart Fail. Rep."},{"key":"32155_CR7","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","volume":"15","author":"M Nakamura","year":"2018","unstructured":"Nakamura, M. & Sadoshima, J. Mechanisms of physiological and pathological cardiac hypertrophy. Nat. Rev. Cardiol. 15, 387\u2013407 (2018).","journal-title":"Nat. Rev. Cardiol."},{"key":"32155_CR8","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.yjmcc.2016.06.001","volume":"97","author":"I Shimizu","year":"2016","unstructured":"Shimizu, I. & Minamino, T. Physiological and pathological cardiac hypertrophy. J. Mol. Cell. Cardiol. 97, 245\u2013262 (2016).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"32155_CR9","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1172\/JCI40295","volume":"120","author":"N Takeda","year":"2010","unstructured":"Takeda, N. et al. Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload. J. Clin. Investig. 120, 254\u2013265 (2010).","journal-title":"J. Clin. Investig."},{"key":"32155_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/978-4-431-87775-2","volume-title":"The biology of Kr\u00fcppel-like factors","author":"R Nagai","year":"2009","unstructured":"Nagai, R., Friedman, S. L. & Kasuga, M. The biology of Kr\u00fcppel-like factors (Springer, 2009)."},{"key":"32155_CR11","doi-asserted-by":"crossref","unstructured":"Pollak, N. M., Hoffman, M., Goldberg, I. J. & Drosatos, K. Kr\u00fcppel-like factors: crippling and uncrippling metabolic pathways. JACC: Basic to Translational Science 3, 132\u2013156 (2018).","DOI":"10.1016\/j.jacbts.2017.09.001"},{"key":"32155_CR12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/jmcb\/mjaa080","volume":"13","author":"Z Xie","year":"2021","unstructured":"Xie, Z. et al. Current knowledge of Kr\u00fcppel-like factor 5 and vascular remodeling: providing insights for therapeutic strategies. J. Mol. Cell Biol. 13, 79\u201390 (2021).","journal-title":"J. Mol. Cell Biol."},{"key":"32155_CR13","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1161\/CIRCRESAHA.115.306383","volume":"118","author":"K Drosatos","year":"2016","unstructured":"Drosatos, K. et al. Cardiac myocyte KLF5 regulates Ppara expression and cardiac function. Circ. Res. 118, 241\u2013253 (2016).","journal-title":"Circ. Res."},{"key":"32155_CR14","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1161\/CIRCULATIONAHA.120.047420","volume":"143","author":"M Hoffman","year":"2021","unstructured":"Hoffman, M. et al. Cardiomyocyte kr\u00fcppel-like factor 5 promotes de novo ceramide biosynthesis and contributes to eccentric remodeling in ischemic cardiomyopathy. Circulation 143, 1139\u20131156 (2021).","journal-title":"Circulation"},{"key":"32155_CR15","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nm.4326","volume":"23","author":"K Fujiu","year":"2017","unstructured":"Fujiu, K. et al. A heart\u2013brain\u2013kidney network controls adaptation to cardiac stress through tissue macrophage activation. Nat. Med. 23, 611\u2013622 (2017).","journal-title":"Nat. Med."},{"key":"32155_CR16","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.yjmcc.2021.10.002","volume":"163","author":"D Palioura","year":"2022","unstructured":"Palioura, D., Lazou, A. & Drosatos, K. Kr\u00fcppel-like factor (KLF) 5: an emerging foe of cardiovascular health. J. Mol. Cell. Cardiol. 163, 56\u201366 (2022).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"32155_CR17","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1111\/cas.14910","volume":"112","author":"Y Luo","year":"2021","unstructured":"Luo, Y. & Chen, C. The roles and regulation of the KLF5 transcription factor in cancers. Cancer Sci. 112, 2097\u20132117 (2021).","journal-title":"Cancer Sci."},{"key":"32155_CR18","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/nm738","volume":"8","author":"T Shindo","year":"2002","unstructured":"Shindo, T. et al. Kr\u00fcppel-like zinc-finger transcription factor KLF5\/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling. Nat. Med. 8, 856\u2013863 (2002).","journal-title":"Nat. Med."},{"key":"32155_CR19","doi-asserted-by":"crossref","unstructured":"Mylonas, N. et al. Cardiac ischemia\/reperfusion increases cardiomyocyte KLF5 in pigs and mice that aggravates tissue injury and remodeling. Cardiovasc. Res., cvaf040 (2025).","DOI":"10.1093\/cvr\/cvaf040"},{"key":"32155_CR20","doi-asserted-by":"crossref","unstructured":"Kiyuna, L. A., e Albuquerque, R. P., Chen, C.-H., Mochly-Rosen, D. & Ferreira, J. C. B. Targeting mitochondrial dysfunction and oxidative stress in heart failure: challenges and opportunities. Free Rad. Biol. Med. 129, 155-168 (2018).","DOI":"10.1016\/j.freeradbiomed.2018.09.019"},{"key":"32155_CR21","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1161\/CIRCRESAHA.124.323800","volume":"135","author":"A Hinton Jr","year":"2024","unstructured":"Hinton, A. Jr. et al. Mitochondrial structure and function in human heart failure. Circ. Res. 135, 372\u2013396 (2024).","journal-title":"Circ. Res."},{"key":"32155_CR22","doi-asserted-by":"publisher","first-page":"647","DOI":"10.14336\/AD.2017.0924","volume":"9","author":"Y-C Yang","year":"2018","unstructured":"Yang, Y.-C. et al. Pkc\u03b4 activation is involved in ROS-mediated mitochondrial dysfunction and apoptosis in cardiomyocytes exposed to advanced glycation end products (ages). Aging Dis. 9, 647 (2018).","journal-title":"Aging Dis."},{"key":"32155_CR23","doi-asserted-by":"publisher","first-page":"816369","DOI":"10.3389\/fcvm.2022.816369","volume":"9","author":"L-N Miao","year":"2022","unstructured":"Miao, L.-N. et al. Role and mechanism of PKC-\u03b4 for cardiovascular disease: current status and perspective. Front. Cardiovasc. Med. 9, 816369 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"32155_CR24","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1093\/cvr\/cvp001","volume":"82","author":"SS Palaniyandi","year":"2009","unstructured":"Palaniyandi, S. S., Sun, L., Ferreira, J. C. B. & Mochly-Rosen, D. Protein kinase C in heart failure: a therapeutic target?. Cardiovasc. Res. 82, 229\u2013239 (2009).","journal-title":"Cardiovasc. Res."},{"key":"32155_CR25","doi-asserted-by":"publisher","first-page":"4302","DOI":"10.3390\/ijms23084302","volume":"23","author":"T Methatham","year":"2022","unstructured":"Methatham, T., Nagai, R. & Aizawa, K. A new hypothetical concept in metabolic understanding of cardiac fibrosis: glycolysis combined with TGF-\u03b2 and KLF5 signaling. Int. J. Mol. Sci. 23, 4302 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"32155_CR26","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1021\/acsmedchemlett.1c00721","volume":"13","author":"T Nakaya","year":"2022","unstructured":"Nakaya, T. et al. Development of low-Molecular-Weight compounds targeting the cancer-associated Klf5 transcription factor. ACS Med. Chem. Lett. 13, 687\u2013694 (2022).","journal-title":"ACS Med. Chem. Lett."},{"key":"32155_CR27","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/2211-5463.13784","volume":"14","author":"Y Taguchi","year":"2024","unstructured":"Taguchi, Y. et al. Peptide mimetic NC114 induces growth arrest by preventing PKC\u03b4 activation and FOXM1 nuclear translocation in colorectal cancer cells. FEBS Open Bio 14, 695\u2013720 (2024).","journal-title":"FEBS Open Bio"},{"key":"32155_CR28","unstructured":"Angela, C. d., van Oort, R. J. & Wehrens, X. H. Transverse aortic constriction in mice. Journal of visualized experiments: JoVE, 1729 (2010)."},{"key":"32155_CR29","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ctrv.2016.12.002","volume":"53","author":"H Abdel-Qadir","year":"2017","unstructured":"Abdel-Qadir, H., Ethier, J.-L., Lee, D. S., Thavendiranathan, P. & Amir, E. Cardiovascular toxicity of angiogenesis inhibitors in treatment of malignancy: a systematic review and meta-analysis. Cancer Treat. Rev. 53, 120\u2013127 (2017).","journal-title":"Cancer Treat. Rev."},{"key":"32155_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11886-017-0846-x","volume":"19","author":"D Jain","year":"2017","unstructured":"Jain, D., Russell, R. R., Schwartz, R. G., Panjrath, G. S. & Aronow, W. Cardiac complications of cancer therapy: pathophysiology, identification, prevention, treatment, and future directions. Curr. Cardiol. Rep. 19, 1\u201312 (2017).","journal-title":"Curr. Cardiol. Rep."},{"key":"32155_CR31","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1056\/NEJMra1100265","volume":"375","author":"JJ Moslehi","year":"2016","unstructured":"Moslehi, J. J. Cardiovascular toxic effects of targeted cancer therapies. N. Engl. J. Med. 375, 1457\u20131467 (2016).","journal-title":"N. Engl. J. Med."},{"key":"32155_CR32","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1161\/01.CIR.0000133187.74800.B9","volume":"109","author":"ET Yeh","year":"2004","unstructured":"Yeh, E. T. et al. Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. Circulation 109, 3122\u20133131 (2004).","journal-title":"Circulation"},{"key":"32155_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3389\/fcvm.2018.00009","volume":"5","author":"J Dong","year":"2018","unstructured":"Dong, J. & Chen, H. Cardiotoxicity of anticancer therapeutics. Front. Cardiovasc. Med. 5, 9 (2018).","journal-title":"Front. Cardiovasc. Med."},{"key":"32155_CR34","doi-asserted-by":"publisher","first-page":"e004160","DOI":"10.1161\/JAHA.116.004160","volume":"5","author":"G Meng","year":"2016","unstructured":"Meng, G. et al. Hydrogen sulfide regulates Kr\u00fcppel-like factor 5 transcription activity via specificity protein 1 S-sulfhydration at Cys664 to prevent myocardial hypertrophy. J. Am. Heart Assoc. 5, e004160 (2016).","journal-title":"J. Am. Heart Assoc."},{"key":"32155_CR35","doi-asserted-by":"publisher","first-page":"14886","DOI":"10.1038\/s41598-021-94169-6","volume":"11","author":"T Methatham","year":"2021","unstructured":"Methatham, T., Tomida, S., Kimura, N., Imai, Y. & Aizawa, K. Inhibition of the canonical Wnt signaling pathway by a \u03b2-catenin\/CBP inhibitor prevents heart failure by ameliorating cardiac hypertrophy and fibrosis. Sci. Rep. 11, 14886 (2021).","journal-title":"Sci. Rep."},{"key":"32155_CR36","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1158\/1535-7163.MCT-15-0600","volume":"15","author":"A Ruiz de Sabando","year":"2016","unstructured":"Ruiz de Sabando, A. et al. ML264, a novel small-molecule compound that potently inhibits growth of colorectal cancer. Mol. Cancer Ther. 15, 72\u201383 (2016).","journal-title":"Mol. Cancer Ther."},{"key":"32155_CR37","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrneph.2016.48","volume":"12","author":"X-M Meng","year":"2016","unstructured":"Meng, X.-M., Nikolic-Paterson, D. J. & Lan, H. Y. TGF-\u03b2: the master regulator of fibrosis. Nat. Rev. Nephrol. 12, 325\u2013338 (2016).","journal-title":"Nat. Rev. Nephrol."},{"key":"32155_CR38","doi-asserted-by":"publisher","first-page":"588347","DOI":"10.3389\/fcvm.2020.588347","volume":"7","author":"S Saadat","year":"2021","unstructured":"Saadat, S. et al. Pivotal role of TGF-\u03b2\/Smad signaling in cardiac fibrosis: non-coding RNAs as effectual players. Front. Cardiovasc. Med. 7, 588347 (2021).","journal-title":"Front. Cardiovasc. Med."},{"key":"32155_CR39","doi-asserted-by":"publisher","first-page":"e48713","DOI":"10.1371\/journal.pone.0048713","volume":"7","author":"C Bolte","year":"2012","unstructured":"Bolte, C. et al. Postnatal ablation of Foxm1 from cardiomyocytes causes late onset cardiac hypertrophy and fibrosis without exacerbating pressure overload-induced cardiac remodeling. PLoS ONE 7, e48713 (2012).","journal-title":"PLoS ONE"},{"key":"32155_CR40","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1161\/CIRCRESAHA.116.302317","volume":"116","author":"DL Mann","year":"2015","unstructured":"Mann, D. L. Innate immunity and the failing heart: the cytokine hypothesis revisited. Circ. Res. 116, 1254\u20131268 (2015).","journal-title":"Circ. Res."},{"key":"32155_CR41","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.cell.2017.03.050","volume":"169","author":"M Hulsmans","year":"2017","unstructured":"Hulsmans, M. et al. Macrophages facilitate electrical conduction in the heart. Cell 169, 510\u2013522 (2017).","journal-title":"Cell"},{"key":"32155_CR42","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/s41591-018-0059-x","volume":"24","author":"G Bajpai","year":"2018","unstructured":"Bajpai, G. et al. The human heart contains distinct macrophage subsets with divergent origins and functions. Nat. Med. 24, 1234\u20131245 (2018).","journal-title":"Nat. Med."},{"key":"32155_CR43","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00018-013-1349-6","volume":"71","author":"P Kong","year":"2014","unstructured":"Kong, P., Christia, P. & Frangogiannis, N. G. The pathogenesis of cardiac fibrosis. Cell. Mol. Life Sci. 71, 549\u2013574 (2014).","journal-title":"Cell. Mol. Life Sci."},{"key":"32155_CR44","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","volume":"128","author":"GD Lopaschuk","year":"2021","unstructured":"Lopaschuk, G. D., Karwi, Q. G., Tian, R., Wende, A. R. & Abel, E. D. Cardiac energy metabolism in heart failure. Circ. Res. 128, 1487\u20131513 (2021).","journal-title":"Circ. Res."},{"key":"32155_CR45","doi-asserted-by":"crossref","unstructured":"Lai, L. et al. Energy metabolic reprogramming in the hypertrophied and early stage failing heart: a multisystems approach. Circulation: Heart Failure 7, 1022\u20131031 (2014).","DOI":"10.1161\/CIRCHEARTFAILURE.114.001469"},{"key":"32155_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40104-016-0139-z","volume":"8","author":"S Zhang","year":"2017","unstructured":"Zhang, S., Zeng, X., Ren, M., Mao, X. & Qiao, S. Novel metabolic and physiological functions of branched chain amino acids: a review. J. Animal Sci. Biotechnol. 8, 1\u201312 (2017).","journal-title":"J. Animal Sci. Biotechnol."},{"key":"32155_CR47","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.bcp.2016.11.008","volume":"123","author":"Y Lu","year":"2017","unstructured":"Lu, Y. et al. Glycine prevents pressure overload induced cardiac hypertrophy mediated by glycine receptor. Biochem. Pharmacol. 123, 40\u201351 (2017).","journal-title":"Biochem. Pharmacol."},{"key":"32155_CR48","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/ejhf.1320","volume":"21","author":"A van der Pol","year":"2019","unstructured":"van der Pol, A., van Gilst, W. H., Voors, A. A. & van der Meer, P. Treating oxidative stress in heart failure: past, present and future. Eur. J. Heart Fail. 21, 425\u2013435 (2019).","journal-title":"Eur. J. Heart Fail."},{"key":"32155_CR49","doi-asserted-by":"publisher","first-page":"921","DOI":"10.33549\/physiolres.933866","volume":"67","author":"M Gyur\u00e1szov\u00e1","year":"2018","unstructured":"Gyur\u00e1szov\u00e1, M. et al. Markers of oxidative stress and antioxidant status in the plasma, urine and saliva of healthy mice. Physiol. Res. 67, 921 (2018).","journal-title":"Physiol. Res."},{"key":"32155_CR50","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/cvr\/cvs333","volume":"97","author":"Y Watanabe","year":"2013","unstructured":"Watanabe, Y. et al. Chronic depletion of glutathione exacerbates ventricular remodelling and dysfunction in the pressure-overloaded heart. Cardiovasc. Res. 97, 282\u2013292 (2013).","journal-title":"Cardiovasc. Res."},{"key":"32155_CR51","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3389\/fphar.2016.00162","volume":"7","author":"S Sasagawa","year":"2016","unstructured":"Sasagawa, S. et al. Downregulation of GSTK1 is a common mechanism underlying hypertrophic cardiomyopathy. Front. Pharmacol. 7, 162 (2016).","journal-title":"Front. Pharmacol."},{"key":"32155_CR52","doi-asserted-by":"publisher","first-page":"15565","DOI":"10.1073\/pnas.1002178107","volume":"107","author":"J Kuroda","year":"2010","unstructured":"Kuroda, J. et al. NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart. Proc. Natl. Acad. Sci. 107, 15565\u201315570 (2010).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"32155_CR53","doi-asserted-by":"publisher","first-page":"15719","DOI":"10.1074\/jbc.M413493200","volume":"280","author":"Z He","year":"2005","unstructured":"He, Z. et al. Differential regulation of angiotensin II-induced expression of connective tissue growth factor by protein kinase C isoforms in the myocardium. J. Biol. Chem. 280, 15719\u201315726 (2005).","journal-title":"J. Biol. Chem."},{"key":"32155_CR54","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s10741-017-9634-3","volume":"22","author":"RM Singh","year":"2017","unstructured":"Singh, R. M., Cummings, E., Pantos, C. & Singh, J. Protein kinase C and cardiac dysfunction: a review. Heart Fail. Rev. 22, 843\u2013859 (2017).","journal-title":"Heart Fail. Rev."},{"key":"32155_CR55","doi-asserted-by":"publisher","first-page":"100757","DOI":"10.1016\/j.jbior.2020.100757","volume":"78","author":"JT Speidel","year":"2020","unstructured":"Speidel, J. T., Affandi, T., Jones, D. N., Ferrara, S. E. & Reyland, M. E. Functional proteomic analysis reveals roles for PKC\u03b4 in regulation of cell survival and cell death: implications for cancer pathogenesis and therapy. Adv. Biol. Regul. 78, 100757 (2020).","journal-title":"Adv. Biol. Regul."},{"key":"32155_CR56","first-page":"1","volume":"18","author":"NP Sert","year":"2020","unstructured":"Sert, N. P. et al. Reporting animal research: Explanation and Elaboration for the ARRIVE guidelines 20. PLOS Biol. 18, 1\u201365 (2020).","journal-title":"PLOS Biol."},{"key":"32155_CR57","doi-asserted-by":"publisher","first-page":"e0211629","DOI":"10.1371\/journal.pone.0211629","volume":"14","author":"DE Long","year":"2019","unstructured":"Long, D. E. et al. A guide for using NIH Image J for single slice cross-sectional area and composition analysis of the thigh from computed tomography. PLoS ONE 14, e0211629 (2019).","journal-title":"PLoS ONE"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32155-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32155-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32155-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:37:57Z","timestamp":1781627877000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32155-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["32155"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-32155-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"15 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this Article was revised: In the original version of this Article, the Supplementary Figure files, which were included with the initial submission, were omitted from the article. The correct Supplementary Information files now accompany the original Article.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2367"}}